Navigation Links
Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support
Date:5/27/2009

Small Molecule Stem Cell Modulator Administered in Dual Cord Blood Transplant for Hematologic Malignancy

LA JOLLA, Calif., May 27 /PRNewswire/ -- Fate Therapeutics, Inc. announced today that the first patient has been treated in a Phase 1b clinical trial of FT1050, a small molecule Stem Cell Modulator (SCM) designed to increase hematopoietic stem cell (HSC) number and function through its activation of key pathways that guide cell fate. The study, which is being conducted at the Dana-Farber Cancer Institute in Boston, Massachusetts, will determine the safety and tolerability of introducing FT1050 during the standard course of dual umbilical cord blood transplant in adult patients with hematologic malignancies, such as leukemia and lymphoma, who have undergone nonmyeloablative conditioning therapy. Fate Therapeutics is developing FT1050 to improve the overall efficiency of HSC treatment by enhancing HSC proliferation and homing to the bone marrow.

"The mission of Fate Therapeutics is to develop small molecules and biologics that modulate adult stem cells within the body for regenerative medicine," said Paul Grayson, president and CEO of Fate Therapeutics. "As our first SCM clinical candidate, FT1050 represents the initial step in our approach - using a small molecule to treat cells ex vivo but creating an in vivo regenerative effect. With FT1050, we are trying to affect stem cell biology in the body, improving the reconstitution of a patient's blood and immune system."

"For patients who need hematopoietic stem cell support, time is of the essence," said Corey Cutler M.D., M.P.H., F.R.C.P.C., assistant professor of medicine, Dana-Farber and Harvard Medical School, and leader of the clinical study. "However, many patients do not have a suitably matched donor, either from a sibling or from an unrelated volunteer in t
'/>"/>

SOURCE Fate Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 A decade-long JDRF-funded ... Helmholtz Zentrum München, Germany , is ... and the risk of developing type 1 diabetes (T1D), ... for the disease. The study, "Seroconversion to Multiple Islet ... was published today in The Journal of the ...
(Date:6/19/2013)... , June 19, 2013 The Physician-Patient Alliance for ... fatigue. The need to urgently address this issue ... Sentinel Event Alert #50 , "Medical device alarm safety in ... between January 2008 and June 2012, there were 98 alarm ... in death (82%) , 13 resulted in permanent loss ...
(Date:6/19/2013)... 2013  Caradigm today announced the availability ... to help healthcare organizations efficiently manage clinician ... their compliance with data privacy regulations. The ... in the delivery of advanced role lifecycle ... systems. (Photo: http://photos.prnewswire.com/prnh/20130619/SF34463LOGO ...
Breaking Medicine Technology:New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3
... Oct. 20, 2011 Treating patients with the new ... in significantly higher per patient costs and higher net ... by pharmacy benefit manager Prime Therapeutics (Prime).The study will ... Pharmacy,s Educational Conference in Atlanta, Ga. Dabigatran ...
... today announced publication of a peer-reviewed paper that examines ... for removal of varicose veins in a clinical office ... Powered Phlebectomy in an Office Setting:  Procedural Considerations and ... M.D., FACS (AmeriVein Systems, Aurora, Illinois) and published in ...
Cached Medicine Technology:Study Finds New Blood Thinning Medication, Pradaxa®, Comes at High Cost 2InaVein, LLC Announces First Peer-reviewed Publication of TRIVEX® Used In-Office 2
(Date:6/19/2013)... Triangle Park, NC (PRWEB) June 19, 2013 ... Entegrion , Inc., announced organizational changes to advance ... John B. Mowell said, “To support the advanced ... Directors has made changes to the Company’s management ... , The Company announced that Michael ...
(Date:6/19/2013)... Dental professionals are increasingly monitoring end ... to moderate sedation, a patient’s breathing depth and rate ... the latest to update its guidelines to require etCO2 ... an effort to increase safety in procedures. This amendment ... goes into effect July 1. , The Oregon ...
(Date:6/19/2013)... at Louisiana State University have developed a method for ... relies on understanding the genetic interaction between single nucleotide ... prostate cancer,s aggressiveness to avoid unnecessary radical treatment. ... PLOS ONE in April. , According to ... all cancers and 9 percent of cancer deaths. It ...
(Date:6/19/2013)... Ariz. (PRWEB) June 19, 2013 PREFERRED ... WellCare of Arizona to offer a new ... Maricopa, Pima, La Paz, Yavapai and Mohave, Arizona counties. ... Mohave counties were effective January 1, 2013 and Maricopa ... 2014. , WellCare, Inc., the parent company of WellCare ...
(Date:6/19/2013)... DiscountFurnaceFilter.com, the number one solution for homeowner’s indoor air quality ... at an exceptional price. The 5-2-1 Compressor Saver (also known ... during start up, saving wear and tear on the system ... , The 5-2-1 Compressor Saver works by assisting ... to start and drastically reduces the rush of heat start ...
Breaking Medicine News(10 mins):Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 2Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 3Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network 2
... Team suggests screening spares patients lifetime of problems , , ... lifetime of problems with getting a good night,s sleep ... attention-deficit hyperactivity disorder (ADHD). , The study of 281 ... with ADHD, found that regardless of the severity of ...
... Takes Place on the Eve of the 8th Annual National ... for 14 straight years, the teen birth rate in the ... in Washington, DC sponsored by The National Campaign to Prevent ... rate is increasing and will explore ways to try to ...
... the Product Offering of Avalign Technologies, Inc.LAKE ... Partners ("RoundTable"), an operating-oriented private equity firm ... today that its portfolio company, Avalign ... of instruments, implants, and delivery systems to ...
... resulting from high-energy blasts is one possible underlying causeROSEMONT, ... who are wounded in combat as the result of ... likely to develop an abnormality known as heterotopic ossification. ... such as muscle located near a fracture or other ...
... LIFE Urges Americans to Think About Income Protection, Offers Tips ... The results of a new survey show the historic ... investments -- and as a consequence, they are more vulnerable ... become sick or hurt and couldn,t work. According to the ...
... and Afghanistan ... To help ease the transition and readjustment challenges facing Iraq and ... America (IAVA) joined the Ad Council today to launch a new ... Campaign. Launched on Veterans Day 2008, the first series of ads ...
Cached Medicine News:Health News:Treating Sleep Disorders May Ease ADHD Symptoms 2Health News:Forum Explores Solutions to the Rise in the Teen Birth Rate 2Health News:Forum Explores Solutions to the Rise in the Teen Birth Rate 3Health News:RoundTable Healthcare Partners Completes Portfolio Company Add-On Acquisition 2Health News:RoundTable Healthcare Partners Completes Portfolio Company Add-On Acquisition 3Health News:Injured Marines at Risk for Abnormal Bone Growth 2Health News:Injured Marines at Risk for Abnormal Bone Growth 3Health News:Hit Hard by the Economy, Americans Risk Knockout Without Disability Insurance 2Health News:Hit Hard by the Economy, Americans Risk Knockout Without Disability Insurance 3Health News:Hit Hard by the Economy, Americans Risk Knockout Without Disability Insurance 4Health News:Video: IAVA and Ad Council Build on Success of Groundbreaking Veterans Campaign with New Friends and Family Element 2Health News:Video: IAVA and Ad Council Build on Success of Groundbreaking Veterans Campaign with New Friends and Family Element 3Health News:Video: IAVA and Ad Council Build on Success of Groundbreaking Veterans Campaign with New Friends and Family Element 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: